Skip to main content
Clinical Trials/ChiCTR1900028256
ChiCTR1900028256Active, not recruitingEarly Phase 1

双靶点重复经颅磁刺激治疗广泛性焦虑障碍的疗效观察

自筹1 site in 1 country20 target enrollmentStarted: December 7, 2020Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
汉密尔顿抑郁量表

Study Overview

Brief Summary

观察额顶双靶点低频 rTMS 治疗 GAD 的疗效,探讨其脑机制。

Study Design

Study Type
干预性研究
Primary Purpose
连续入组
Masking
None

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • 18-65 周岁;符合 DSM-5 中 GAD 诊断标准;HAMA>14 分;近 1 周内未服用抗抑郁药或苯二氮卓类药物。

Exclusion Criteria

  • 合并其它类型焦虑障碍;合并双相情感障碍、精神分裂症等精神疾病;合并神经系统疾病;有颅脑外伤或手术史;EEG 和 MRI 检查禁忌;妊娠及哺乳期。

Arms & Interventions

Group 2

单靶点额叶刺激

Group 1

额顶双靶点刺激

Outcomes

Primary Outcomes

汉密尔顿抑郁量表

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials